Company attributes
Venture Capital Firm attributes
Other attributes
Lux Capital Management was founded in 2000 by Josh Wolfe, Peter Hebert and Rob Paull. It is headquartered in New York, New York with additional offices in Menlo Park, California and San Diego, California. It is a venture capital firm specialising in investments in seed, early stage investments, special situations, and corporate spinouts in areas of energy, life sciences, biopharmaceutical, healthcare and technology. In addition to seeking to be a first institutional investor in its portfolio companies, it also provides follow on funding for future financing rounds. Lux Capital is headquartered in New York with an additional office in Menlo Park and San Diego California.
The company seeks to invest in emerging technologies in areas of advances materials, drug delivery, therapeutics, mobile health, novel materials, energy technology, wireless, semiconductors, nanotechnology and biotechnology sectors. The firm also invests in machine learning, artificial intelligence, 3D printing, meta materials, robotics and solid-state electronics. Life science areas include augmented reality for the blind, neurostimulation, age extending blood transplants, synthetic biology for industry and Internet of things security for industrial and factory automation.
The firm invests in energy, life sciences, biopharmaceutical, healthcare, and technology. It also invests in emerging technologies with a focus on advanced materials, drug delivery, energy technology, nanotechnology, alternative energy technologies, and biotechnology sectors. It also invests in augmented reality for the blind, neuro-stimulation and age extending blood transplants. The firm invests between $0.1 million in companies and invests up to $20 million in a startup.
Lux Capital has raised a total of $1.1 billion across 5 funds, their latest being Lux Capital Co-Investment Fund.
Investments include Auris Health Inc., Noxomi Networks and Aeva and exits including Alluvium, AltspaceVR and EverSpin Technologies.